PARP Inhibitors in Ovarian Cancer

N Engl J Med. 2020 Apr 16;382(16):1573-1574. doi: 10.1056/NEJMc2000644.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bevacizumab
  • Female
  • Humans
  • Ovarian Neoplasms*
  • Phthalazines
  • Piperazines
  • Poly(ADP-ribose) Polymerase Inhibitors*

Substances

  • Phthalazines
  • Piperazines
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Bevacizumab
  • olaparib